| 000 | 01502 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516204621.0 | ||
| 264 | 0 | _c20140703 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(13)70607-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHall, Jacqueline Anne | |
| 245 | 0 | 0 |
_aA risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cApr 2014 |
||
| 300 |
_ae184-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aChecklist |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNational Cancer Institute (U.S.) _xeconomics |
| 650 | 0 | 4 |
_aNeoplasms _xmetabolism |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aResearch Support as Topic |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aRisk Management |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aSalgado, Roberto | |
| 700 | 1 | _aLively, Tracy | |
| 700 | 1 | _aSweep, Fred | |
| 700 | 1 | _aSchuh, Anna | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 15 _gno. 4 _gp. e184-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(13)70607-7 _zAvailable from publisher's website |
| 999 |
_c23701188 _d23701188 |
||